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Summary
Identifying the immunogenic proteins that elicit pathogen-specific T cell responses is key to ra-
tional vaccine design. While several approaches have succeeded in identifying major histocom-
patibility complex (MHC) class I bound peptides that stimulate CD8+ T cells, these approaches
have been difficult to extend to peptides presented by MHC class II molecules that stimulate
CD4+ T cells. We describe here a novel strategy for identifying CD4 + T cell-stimulating antigen
genes. Using Listeria monocytogenes-specific, lacZ-inducible T cells as single-cell probes, we
screened a Listeria monocytogenes genomic library as recombinant Escherichia coli that were fed to
macrophages. The antigen gene was isolated from the E. coli clone that, when ingested by the
macrophages, allowed generation of the appropriate peptide/MHC class II complex and T cell
activation. We show that the antigenic peptide is derived from a previously unknown listeria
gene product with characteristics of a membrane-bound protein.
D4+ and CD8+ T cells recognize peptide/MHC com-
plexes on the surface ofAPCs and are normally required
for protective immunity. The peptide antigens presented
by MHC class 11 and recognizedby CD4+ T cells are ofpar-
ticular interest in that CD4+ T cells have been shown to
play a central role in immunity to bacterial pathogens as well
as in autoimmune diseases (1-3) . The existence of thousands
of different peptides bound to the MHC class II molecules
on the cell surface, however, makes it very difficult to iden-
tify the unique antigenic peptide that is recognized by any
one particular T cell (4-6) .
In contrast to successful identification of several antigen/
MHC class I complexes recognizedby CD8+ T cells (7-11),
available methods for identifying CD4+ T cell-stimulating
antigens have had little success. The difficultie result prima-
rily from conventional methods for generating peptide/
MHC class II complexes in APCs and for detecting these
APCs by T cell activation assays. In conventional bulk as-
says, CD4+ T cell responses are usually detected only when
APCs are incubated with purified proteins in the nano- to
micromolar concentration range. With the exception of the
abundantly expressed ribosomal L9 protein that was recently
identified as the source ofa peptide/Ek complex recognized
by tumor-specific CD4+ T cells (12), antigenic proteins from
complex extracts have been difficult to obtain in amounts
and purity sufficient for their identification. Likewise, anti-
genic peptides eluted from MHC class II are difficult to pu-
rify to homogeneity because only small amounts are expressed
by the APCs and they are heterogenous with respect to size
(amino acids 13-25) (references 4-6, 13) . Alternative anti-
body-based strategies suffer from the additional disadvantage
that only proteins that share B and T cell epitopes can be
identified, and it is possible that the proteins that elicit pro-
tective T cell immunity are different from those that induce
a humoral immune response.
We describe here a novel and simple strategy for genetic
identification of CD4+ T cell-stimulating antigens. First, in-
stead of generating peptide/MHC class II complexes by the
conventional method of adding proteins exogenously to
APCs, we obtained these complexes in macrophages fed with
recombinant bacteria that expressed the antigen genes. Sec-
ond, we detected the expression of these peptide/MHC class
II complexes with an exquisitely sensitive single T cell assay
(14, 15). Together, these methods allowed us to identify a
previously unknown CD4+ T cell--stimulating antigen ex-
pressed by the Gram-positive pathogen Listeria monocyto-
genes (LM)1.
Materials and Methods
Cell Lines, Antibodies, and Mice.
￿
All mammalian cells were main-
tained in RPMI 1640 supplemented with 10% fetal bovine serum
(Irvine Scientific, Irvine, CA), 2 mM glutamine, 1 mM pyruvate,
50 p,M 2-mercaptoethanol, 200 U/ml penicillin, and 200 ~Lg/ml
streptomycin at 37°C in a 5% C02/air atmosphere incubator.
The BWZ.36 and BWZ.36 CD4+ fusion partners have been de-
scribed elsewhere (16). The B cell lymphoma LK35.2 (H-2kxd)
and the hybridomas 10.2.16 (anti-A) and 14.4.4S (anti-Ek) were
Abbreviations used in this paper: CPRG, chlorophenol red-R galactoside;
HKLM, heat-killed LM; IPTG, isopropyl-(3-v-thiogalactopyranoside;
LM, Listeria monocytogenes; rpm, revolutions per minute; X-GAL, 5-bromo-
4-chloro-3-indolyl a-galactopyranoside.
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Volume 182 December 1995 1751-1757from American Type Culture Collection (Rockville, MD). The
mAb 3.155 (anti-CD8) was kindly provided by Dr. J.P. Allison
(University of California, Berkeley). The polyclonal goat anti-rat
antibodies were obtained from Southern Biotechnology Associ-
ates (Birmingham, AL), Male and female CBA/J (H-2k) mice
were obtained from the Jackson Laboratory (Bar Harbor, ME)
and were used between the ages of2-10 mo.
LM.
￿
LM strain 85EO-1167 was an isolate from the California
State Health Department kindly provided by Dr. Karen Grant (De-
partment ofPublic Health, University ofCalifornia, Berkeley). Ini-
tially, LM was streaked out on brain heart infusion broth 1.5% agar
plates, and a single clone was isolated and frozen in 10% DMSO.
LM was grown in liquid culture in brain heart infusion broth for
all other experiments. Heat-killed LM (HKLM) was prepared as
follows (17). LM cells from overnight cultures were pelleted for
15 min at -4,000 rpm, resuspended to 109 per ml in PBS, and in-
cubated in an 80°C bath for 1 h. The cells were washed once
with PBS to remove soluble LM proteins and then resuspended
to the same volume in PBS. Afterverifying the completion of kill-
ingby absence ofgrowth on brainheart infusion broth/agar plates,
the HKLM was aliquoted and stored at 4°C.
LM-specific T Cells.
￿
For immunizations, CBA mice were im-
munized intraperitoneally with 105 LM suspended in PBS. 6 d af-
terimmunization, spleens from immunized animals were harvested
and depleted of B cells and macrophages by passage over nylon
wool columns as described (17, 18). Cells were enriched for
CD4+ T cells by panning over anti-CD8 (mAb 3.155)-coated
petri dishes. Nonadherent cells were collectedand incubated with
107 HKLM/ml and 5 X 105/nil irradiated (1,400 rads) syngeneic
spleen cells in amedium containing 100 fig/ml gentamicin to en-
rich in vitro for antigen-specific T cells. After 5 d, cells were har-
vested, washed, and cultured in complete RPMI + 100 U/ml re-
combinant human IL-2 for 3 d and fused with the BWZ.36 or
BWZ.36 CD4+ fusion partner using polyethylene glycol (PEG
1500; Boehringer Mannheim Biochemicals, Indianapolis, IN), as
described (16). Hybrids were screened for specificity using synge-
neic CBAsplenic cells as APC and HKLM as the antigen.
Antigen/MHC-Specific TCell Stimulation Assays.
￿
105 T cell hy-
brids were cocultured overnight with the appropriate APC (peri-
toneal macrophages, syngeneic irradiated spleen, or LK35.2 lym-
phoma) in medium alone or in the presence of the indicated
concentration of antigen. Peritoneal macrophages, used as APC
for particulate bacterial antigens, were elicited by intraperitoneally
injecting CBA mice with aged thioglycollate 3-4 d before the ex-
periment, as described (18-20). The animals were killed, and the
macrophages were collected by washing the peritoneum with
PBS; they were plated in 96-well plates at a density of 105 cells
per well. Plates were centrifuged for 1 min at 1,000 rpm andthen
incubated at 37°C to allow adherence of macrophages. After 2 h,
nonadherent cells were removedby washing; the remaining cells
were incubated overnight in medium containing 100 U/ml IFN- Y
(Genzyme, Boston, MA). The next day, cells were washed and
placed in antibiotic-free medium. The indicated number of bac-
teria, also in antibiotic-free medium, were added to the activated
macrophages. Plates were spun and incubated at 37°C to allow
phagocytosis ofbacteria. After 1 h, bacteria were washed offand
T cells were added in medium with the antibiotic gentamicin
(200 N,g/ml) to assay the expression of peptide/MHC complexes.
T cell activation wasmeasured as lacZ expression in single cells
or in bulk cultures with 5-bromo-4-chloro-3-indolyl (3-galacto-
pyranoside (X-GAL; Sigma Immunochemicals, St. Louis, MO) or
chlorophenolred-(3 galactoside (CPRG; Calbiochem, San Diego,
CA) substrates, respectively (14-16). Briefly, for single T cell as-
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says, individual cultures were washed once with PBS and the cells
were fixedwith cold 2% formaldehyde/0.2% gluteraldehyde for 5
min at 4°C. Cells were washed again in PBS and then overlaid
with a 100 RI solution containing 1 mg/mlX-GAL, 5 mM potas-
sium ferrocyanide, 5 mM potassium ferricyanide, and 2 mM
MgCl2 in PBS. The cultures were examined microscopically for
the presence oflacZ+ blue cells after 6-18 h at 37°C. For bulk T
cell assays, cultures in the microtiter plates were washed once
with PBS and then lysed by addition of 100 N.1 PBS buffer con-
taining 100 k,M 2-mercaptoethanol, 9 mM MgCl,, 0.125% NP40,
and 0.15 mM CPRG. After 4-6 h at 37°C, 50 RI stop buffer (300
mM glycine and 15 mM EDTA in water) was added, and the ab-
sorption of each well was determined at 595 nm using a 96-well
plate reader. Results of representative experiments are shown as
average of replicate cultures, with standard deviations (<10%)
omitted for clarity.
Genomic Expression Libraryfrom LM.
￿
Genomic LM DNA was
prepared as described, partially digested with Sau3A, and size frac-
tionated on an agarose gel to isolate 1-4-kb DNA fragments (21).
DNA was purified by electroelution and ligated to dephosphory-
lated BglII cut pTrcHis C vector (Invitrogen, San Diego, CA).
The ligated plasmids were transformed into the TOP10F' strain
ofEscherichia coli by electroporation and plated onto selective (100
l tg/ml ampicillin) L broth/agar plates to quantitate transformation
efficiency.
Screening ofLM Expression Library.
￿
Transformed bacteria were
resuspended in selective media to give -100-300 transformants
per ml, and 0.1 ml were plated into each well of96-well microti-
ter plates. The plates were grown overnight at 37°C with shak-
ing. Replicate cultures were made by splitting the overnight cul-
tures 1:10 into fresh plates and storing the original as the master
plate at 4°C. Freshly split plates were grown for 30-45 min at
37°C, afterwhichprotein expression was inducedby the addition
ofisopropyl-R-D-thio-galactopyranoside (IPTG; Sigma) to a final
concentration of 1 mM. After2 h ofinduction, the plates were cen-
trifuged for 2 min at 2,000 rpm, the medium was removed, and
the bacteria were resuspended in an equal volume of antibiotic-
free medium. 25-75 RI bacteria were added to IFN-y-activated
macrophages. To allow for phagocytosis of bacteria, the macro-
phages were washed and resuspended in complete medium after
1 h. T cells were added to the cultures, and after overnight incu-
bation, lacZ+ cells were visualized by staining with the X-GAL
substrate, as described above.
Analysis ofClone 3A.1.1 .
￿
The 0.6-kb deletion construct, R10,
was made by deleting the 1-kb fragment between the internal-
and the flanking vector-derived EcoRI sites in clone 3A1.1 . The
C7 deletion construct was made by ligating the 1-kb EcoRI frag-
ment of 3A1.1 into EcoRl cut and dephosphorylated pTrcHis C
vector. This plasmid, C7, contained the 1-kb 3' fragment in the
orientation opposite that in the original 3AL1 clone. The 815.9
fusion construct was generated by first digesting the 3AL1 plas-
midwith Aval that removed the DNA between the 5' Aval site
in the polylinker and the Aval site 3' to the promoter elements
(see Fig. 5) . Blunt ends generated by mung-bean nuclease were
religated to yield an in-frame fusion ofthe p3A1 residues with the
NH2-terminal polyhistidine residues in the vector (see Fig. 4 A).
For analysis of the antigenic protein, overnight cultures of 815.9
bacteria were diluted 1:100 into 1 liter of medium, grown until
OD611o = 0.5, and inducedwith 1 mM IPTG for 5 h. Total pro-
tein extracts were prepared and the metal binding proteins were
purified by passage over Ni-NTA resin (Qiagen, Chatsworth, CA),
according to the manufacturer's instructions . The eluted proteins
were desalted by centrifugation through 5-kD cutoff filters (Milli-pore, Bedford, MA), and the retentates were used as exogenous
antigens with LK35.2 APC, as described above.
Results and Discussion
Generation and Characterization of lacZ-inducible, LM-speci u
T Cell Hybrids. LM has been extensively studied as a model
for immunity to intracellular pathogens (2, 22) . Optimal
protective immunity to LM is T cell mediated and requires
both CD4+ and CD8+ T cells (23-25) . Whereas the mecha-
nisms of LM virulence have been studied extensively, only
two antigens recognized by CD8+ T cells have been iden-
tified recently (8, 26), and relatively little is known about
the antigens that elicit LM-specific CD4+ T cell responses
(2, 27) . To obtain R-galactosidase (lacZ)-inducible, LM-
specific T cell hybrids, CD4+ T cells from LM-immunized
CBA (H-2k) mice were fused with the BWZ.36 T cell fu-
sion partner that contains the lacZ gene under transcrip-
tional control of the NFAT element of the IL-2 enhancer
(16, 17) . As demonstrated previously with other antigens
(11, 16), the resulting T cell hybrids expressed lacZ activity
specifically upon stimulation with HKLM and syngeneic
spleen cells as APC. The LM-specific hybrids were either
Ak (LMZ30.4, LMZ23.1) or Ek (LMZ22.2, LMZ25.4) re-
stricted, as indicated by specific inhibition with either
10.2 .16 (anti-Ak) or 14.4.4S (anti-Ek) mAbs (Fig. 1). Thus,
the LM-specific CD4+ T cell response was heterogeneous.
Isolation of the T Cell-stimulating LM Antigen Gene.
￿
To
identify the LM antigens recognized by these CD4+ T
cells, an expression library was constructed by ligating 1-4 kb
LM genomic DNA fragments into the bacterial expression
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vector pTrc HisC (see Materials and Methods) . Expression
of recombinant LM proteins was induced in E. coli by
growing pools oftransformed bacteria in 96-well plates and
treating the cells with IPTG for 2 h. Aliquots of IPTG-
induced bacteria were transferred to another 96-well plate
containing syngeneic peritoneal macrophages that were al-
lowed to phagocytose the bacteria for 1 h. After washing off
excess bacteria, expression of the antigen/MHC complexes
on the macrophage surface was determined by probing
with the lacZ-inducible LM-specific T cell hybrids . Finally,
the cultures were fixed and stained with the X-GAL substrate
to visualize the activated lacZ + "blue" T cells (15, 16).
With LMZ30.4 (LM/A') T cells, bacterial pools were
screened for the presence of the corresponding antigen at a
complexity of -103 recombinants per 96-well plate. Mac-
rophages fed with one of the bacterial pools, 3A1, stimulated
LMZ30.4 T cells, as indicated by the presence of 50-100
lacZ+ blue cells, over a background of 0-5 blue cells in
other wells (Fig. 2, A and B) . The same bacterial pool failed
to generate the peptide/MHC complexes recognized by an-
other LM/Ak-specific T cell, LMZ23.1, suggesting that this
pool contained only the antigen recognized by LMZ30 .4
(Fig. 2 D) . By repeating the assay with individual colonies
derived from pool 3A1, a single bacterial colony, 3A1 .1,
was obtained that yielded a dramatically higher number of
lacZ+ LMZ30 .4 T cells (Fig. 2 C).
Characterization of Clone 3A1.1 and Its Gene Product.
￿
The
response of LMZ30.4 T cells to 3A1 .1 bacteria was both
antigen specific and Ak MHC restricted, as demonstrated
by the dose-dependent stimulation of LMZ30.4 but not
LMZ23.1 (LM/Ak) T cells and by the specific inhibition of
107 106
Figure 1. Generation of LM/Ak- and LM/Ek-specific
T cell hybrids. 105 of the indicated T cell hybrids were
cultured overnight with 5 X 105 CBA (H-2k) spleen cells
as APC and varying concentrations of HKLM with me-
dium alone (") or in the presence of either the anti-Ak
antibody (10.2.16) (O) or the anti-Ek antibody (14.4.45)
("). T cell response was measured as induced lacZ activ-
ity by usingthe CPRG substrate.Figure 2. Isolation ofthe 3AL1 antigen gene from the LM expression library using the LMZ 30 .4 T cell hybrid as a single-cell probe for the cognate
peptide/MHC complex . Peritoneal CBA (H-2k) macrophages were fed pools ofrecombinant bacteria expressing a genomic LM library . 10 5LMZ 30 .4 T
cells were added to the cultures and 24 h later were assayed for presence oflacZ' cells with the X-GAL substrate (16) . The blue IacZ' cells, indicating
the presence of the antigen, are easily visible over the unstained background representing APC and unactivated T cells. The panels show photo micro-
graphs ofthe LM/Ak-specific LMZ 30.4 T cells responding to (A) a negative pool of recombinants, (B) the positive pool 3A1, and (C) the single colony
3Al .1 isolated from pool 3A1 . In (D), a different LM/A'--specific T cell (LMZ 23 .1) was not stimulated by the same 3A1 bacterial pool. X25 .
this response with 10.2.16 (anti-Ak) but not 14.4.4S (anti-
Ek) mAbs (Fig . 3) . The 3A1 .1 plasmid therefore encoded
the LM gene that allowed expression of the peptide/Al com-
plex recognized by LMZ30.4 T cells .
The 3AL1 plasmidDNA was analyzed to identify the an-
tigenic LM protein termed p3A1 . The size of theDNA in-
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sert in 3A1 .1 was 1 .6 kb (Fig. 4 A) . An internal EcoRl re-
striction site, -0.6 kb from the 5' end ofthe insert in 3A1,1,
as well as anEcoRl site in the 3' end ofthe vector polylinker
were used to generate the R10 and C7 deletion constructs
of the cloned 3Al .1 DNA (Fig . 4 A) . The T cell-stimulat-
ing activity was retained within the 1-kbDNA insert of C7,
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Figure 3. The LMZ 30.4 re-
sponse to 3AL 1 is antigen specific
and Ak restricted . Peritoneal mac-
rophages from CBA mice (H-2k)
were incubated with varying num-
bers of IPTG-induced bacteria ex-
pressing the vector alone (O) or
3A1 .1 plasmid in medium (0) or
in the presence of the anti-Ak (A),
the anti-E' (,~s) mAbs or HKLM
(") (17) . After 1 h, excess bacteria
were washed off and the macro-
phages were incubated with either
(A) LMZ30 .4 or (B) LMZ23 .1 T
cells. T cell response was assayed by
measuring the induced lacZ activity
with the CPRG substrate (16) .A
￿
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￿
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Figure 4. (A) Schematic representation ofthe 1 .6-kb 3A1.1 clone, its derivative DNA constructs, and their ability to stimulate the LMZ30.4 T cell re-
sponse. The DNA fragments are filled in or shaded to indicate their relationship to the original 3A1 .1 clone. All constructs were prepared in the bacterial
expression vector pTrcHis that allows IPTG-inducible transcription of DNA inserts and expression ofin-frame fusion proteins with the metal binding
polyhistidine tag. The internal EcoRl, Aval, and the vector-derived Hindlll sites are indicated to show relative orientation ofthe insert with respect to
the 5' vector-encoded promoter elements. (B and C) The LMZ30.4-stimulating activity of clone 3A1 .1 maps to the 3' 1-kb DNA fragment and within
the p3A1 protein encoded by this fragment (A). Bacteria expressing the clone 3A1.1, its deletion constructs C7 or R10 (B), or the p3A1 fusion protein
815.9 (C were incubated with (+, closed symbols) or without (-, open symbols) IPTG for 2 h, and then assayed for their ability to generate the peptide/A'
complex recognized by LMZ30.4 T cells, as in the legend to Fig. 2. (D) Extracts ofbacteria expressing 815.9 fusion protein contain the LMZ30.4-stim-
ulating antigen. Bacteria expressing the fusion construct 815.9 or the vector alone were treated with (+, closed symbols) orwithout (-, open symbols) IPTG
for 5 h. Bacterial extracts were passed over a Ni-resin column to enrich the fusion protein, and the eluted proteins were added to 3 X 104 LK35.2
(H-2kxd) cells as APC. The anti-Ak mAb, 10.2.16, or the anti-Ek mAb, 14.4.4, were included in the cultures as indicated.
despite its opposite transcriptional orientation with respect
to the IPTG-inducible promoter in the vector (Fig. 4 B).
Indeed, strong LMZ30 .4 T cell responses were observed
with either 3A1 .1 or its C7 deletion construct, regardless of
whether the bacteria were pretreated with IPTG, suggest-
ing that the cloned DNA insert contained constitutive pro-
moter elements for the p3A1 antigen gene (Fig. 4 B) . This
was directly confirmed upon analysis of the nucleotide se-
quence that revealed the presence of a prokaryotic promoter,
and a ribosome binding site preceding the open reading frame
encoding 253 residues that extended into the vector to yield
a protein of 268 amino acids (Fig. 5). No significant simi-
larities were found for either the DNA sequence or for the
predicted p3A1 protein in the sequence databases. A con-
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sensus prokaryotic lipid attachment motif (ILGAC) (28, 29)
was present within the amino acid sequence (Fig. 5), how-
ever, suggesting that the 3A1 protein may be a membrane-
bound lipoprotein.
To establish conclusively that this predicted p3A1 protein
was the source of the antigenic peptide, the Aval/HindIII
DNA fragment, lacking the promoter elements, was used
to generate an IPTG-inducible fusion protein 815.9, with
an NHz-terminal metal binding polyhistidine tag (Fig. 4 A) .
In contrast to the LMZ30.4 response to 3A1 .1 and C7 con-
structs that did not require IPTG induction, the response to
bacteria expressing the 815 .9 fusion protein was obtained
only upon IPTG induction (Fig. 4 C) . SDS-PAGE analysis
of bacterial extracts passed over a Ni-resin column to en-K D L q m v p y g n s k 1 g c £ g g -
rich the fusion protein revealed a faint band of 33 kD that
corresponded to its predicted size (data not shown) . Finally,
only the extracts of IPTG-induced 815.9 bacteria were
active in stimulating the Ak MHC-restricted response of
LMZ30.4 T cells when added exogenously to LK35 .2
(H-2kxd) lymphoma cells as APC (Fig. 4 D). This result
demonstrates formally that the antigenic activity was due to
the p3Al protein itself rather than to an indirect effect of
the ingested bacteria on some other cellular gene. Taken
together, these results establish that the peptide presented
by Ak MHC class II molecules to LMZ30.4 T cells is de-
rived from the p3A1 protein.
The p3A1 protein stimulated the LM/Ak-specific hybrid
LMZ30.4 but none of five other LM/Ak- or LM/Ek-spe-
cific hybrids that were tested (Fig. 3 B and data not shown),
indicating the existence ofheterogeneity in the CD4+ T cell
responses to pathogenic LM bacteria. This result confirms
previous results based on fractionation and analysis of com-
1756
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Figure 5. The nucleotide and predicted amino acid se-
quence ofthe antigenic LM protein that is recognized by
LMZ30.4 T cells. The p3A1 open reading frame is pre-
ceded by consensus sequences of the prokaryotic pro-
moter and the ribosome binding site shown in bold let-
ters. The lipid attachment site characteristic of membrane
lipoproteins is underlined (28, 29). The 253 amino acids
encoded by the insert are in uppercased single-letter
code; those encoded by the vector are in lowercase. The
vertical arrow indicates the 5' end of the fragment used
to construct the 815.9 fusion protein.
plex bacterial extracts (30, 31) . Efforts to identify these other
LM antigens are in progress. Future studies on the role of
this and other LM antigens in eliciting protective immunity
to live LM as well as their role in the life cycle of the patho-
gen will yield additional insights into the mechanism ofvir-
ulence and immunity to intracellular pathogens.
In conclusion, we have established a novel expression clon-
ing strategy for identifying antigens presented by MHC class
II molecules that are recognized by CD4+ T cells. Because
antigenic proteins of either prokaryotic or eukaryotic ori-
gin can be expressed in E. coli and allow generation ofpep-
tide/MHC class II complexes (20, 32), we expect this strat-
egy to be widely applicable. Extension o£these methods are
likely to allow the identification of other CD4+ T cell-stim-
ulating antigens that provide immunity to pathogenic mi-
croorganisms such as Mycobacterium tuberculosis or Mycobacte-
rium leprae as well as those involved in autoimmune disorders.
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GTTTTGACAGAAAGCTCTGACTAACATTATATCTCTCGGGAGGGGTTTTAAGOTGAAAAAGCGTACATTIGCTTTAGCAC
1 ---------,---------,---------,_--------,---------,--------_,---------,---------, 80
V K K R T F A L A L
TATCAATGATTATTGCTTCTGGCGTTATCCTAGGTGCTTGTGGTTCGAGTAGCGACGATAAAAAAAGTAGCGATGATAAG
81 --------------------------------------- ---------------------------------------- 160
S M I I A S G V I L G A C G S S S D D K K S S D D K
AGCAGTAAAGATTTTACAGTAGCAATGGTTACAGATACTGGTGGCGTTGATGACCGTTCGTTTAACCAATCAGCAIGGGA
161 ---------,-____---_-__-___----_-______-,__----------__---__,_-____---,--------_, 240
S S K D F T V A M V T D T G G V D D R S F N Q S A W E
AGGCTTACAAAAATTTGGTAAAGCTAACGACATGGAAAAAGGTACAGATGGTTACAACTACTTGCAATCAGCTTCTGAAG
241 ---------,__-------,_-------_,---____--,_-------_,---___- _,_-______-I---------, 320
G L Q K F G K A N D M E K G T D G Y N Y L Q S A S E A
CAGACTACAAAACAAACTTAAACACTGCTGTTCGTAGCGATTATGATTTAATTTATGGAATTGGTTACAAACTGAAAGAT
321 ---------,_--------,---------,--------_,----____-,_____----,------___-_-------_, 400
D Y K T N L N T A V R S D Y D L I Y G I G Y K L K D
GCAATTGAAGAAGTTTCTAAACAAAAACCTAAAAATCAATTCGCTATTGTTGATGACACAATTGATGACCGTGATAATGT
401 __ -__--_,-____----,-______--,---------,----_____,_ ____-_,_--------,---__-___, 480
A I E E V S K Q K P K N Q F A I V D D T I D D R D N V
AGTAAGTATTGGATTTAAAGATAACGATGGTTCTTATCTAGTTGGTGTAGTAGCTGGCTTAACAACAAAAACAAATAAAG
481 ---------,--------_,_---__---,_--------,---------,_---_____,________-,_______-_, 560
V S I G F K D N D G S Y L V G V V A G L T T K T N K V
T"MGATTTGTTGGTGGAGTAAAAGGAACTGTTATCGACCGTTTTGAAGCTGGTTTCACTGCTGGTGTAAAAGCTGTTAAT
S61 -------------------------------------------------------------------------------- 640
G F V G G V K G T V I D R F E A G F T A G V K A V N
CCTAACGCACAAATTGATGTACAATATGCAAACGATTTCGCTAAAGCAGACAAAGGACAACAAATCGCTTCTTCCATGTA
641 --------_,_--------,_------__,___-____-,---___---,--------_,_-------_,_--------, 720
P N A Q I D V Q Y A N D F A K A D K G Q Q I A S S M Y
TTCGAGTGGAGTTGACGTAATTTTCCATGCTGCTGGTGGTACTGGTAACGGTGTCTTTGCAGAAGCTAAAAATCTGAAGA
721 __---__-_,_--------,--------_,_--------,---__---_,-------__,_____--__,_--------, 800
S S G V D V I F H A A G G T G N G V F A E A K N L K K
AAAAAGATCTGCAGATGGTACCATATGGGAATTCGAAGCTTGGCTGTTTTGGCGGATGA
801 ----------------------------------------------------------- 859References
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